Company Filing History:

4 out of 81

Alcon Manufacturing, Ltd.

patents

Years Active: 2001-2020

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10584307 - Use of PEO-PBO block copolymers in ophthalmic compositions (2020-03-10),

2. 9574160 - Use of PEO-PBO block copolymers in ophthalmic compositions (2017-02-21),

3. 8318144 - Use of PEO-PBO block copolymers in ophthalmic compositions (2012-11-27),

4. 7344725 - Use of inorganic nanoparticles to stabilize hydrogen peroxide solutions (2008-03-18),

5. 6936640 - Biguanide/quaternary ammonium containing copolymeric biocides and use thereof in pharmaceutical compositions (2005-08-30),

6. 6916958 - Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2005-07-12),

7. 6664294 - Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2003-12-16),

8. 6423748 - Amido polybiguanides and the use thereof as antimicrobial agents (2002-07-23),

9. 6316669 - Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions (2001-11-13),

Title: Innovator Profile: Nathaniel D McQueen – Leader in Ophthalmic Innovations

Introduction: Nathaniel D McQueen, based in Vienna, VA, is an accomplished inventor whose work has significantly impacted the field of ophthalmic compositions. With a prolific output of 9 patents, McQueen has been at the forefront of innovative solutions that enhance medical devices and contact lenses.

Latest Patents: Among his notable inventions is the use of poly(oxyethylene)-poly(oxybutylene) block copolymers in ophthalmic compositions. This innovation involves modifying the surfaces of contact lenses and other medical devices to improve their functionality. McQueen's research revealed that these copolymers are especially effective at wetting hydrophobic surfaces, such as silicone hydrogel contact lenses. This discovery not only facilitates better application and comfort for users but also offers potential cleaning applications, positioning the compounds as essential surfactants in the treatment of contact lenses.

Career Highlights: McQueen's extensive experience includes significant roles at prestigious companies, including Alcon Manufacturing, Ltd. and Alcon, Inc. His dedication to research and development has led to breakthroughs that advance both the science of optics and patient care. His patents reflect a commitment to improving health outcomes through innovative technology in ophthalmology.

Collaborations: Throughout his career, McQueen has collaborated with prominent figures in the field, including Joonsup Park and Howard Allen Ketelson. These partnerships have fostered a collaborative environment that has further propelled advancements in the design and functionality of ophthalmic products.

Conclusion: Nathaniel D McQueen is not only a patent holder but also a visionary in the field of ophthalmic innovations. His work exemplifies how targeted research can result in practical applications that enhance the quality of life for users of medical devices. As the industry continues to evolve, McQueen's contributions will undoubtedly play a crucial role in shaping the future of ophthalmic technologies.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com